Worldwide Sustainability Profile
Worldwide, also known as Worldwide Clinical Trials, is a prominent player in the global clinical research industry, headquartered in the United States. Founded in 2007, the company has established a strong presence across North America, Europe, and Asia, providing comprehensive services in drug development and clinical trial management. Specialising in Phase I-IV clinical trials, Worldwide is recognised for its innovative approach and commitment to quality, offering unique solutions that streamline the research process. The company’s core services include clinical trial design, patient recruitment, and data management, all tailored to meet the specific needs of its clients. With a reputation for excellence, Worldwide has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical and biotechnology companies. Its dedication to advancing medical research continues to set it apart in a competitive market.
DitchCarbon Score
How does Worldwide's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Worldwide's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Worldwide's reported carbon emissions
As of the latest available data, Worldwide Clinical Trials has not reported any specific carbon emissions figures. However, the company is committed to achieving net-zero emissions, as indicated by its near-term target status of "Committed" under the Science Based Targets initiative (SBTi). This commitment reflects a proactive approach to climate action within the pharmaceuticals, biotechnology, and life sciences sector. While no absolute emissions data is available, Worldwide Clinical Trials is actively working towards reducing its carbon footprint and aligning with global climate goals. The company is based in the United States and is focused on implementing sustainable practices to mitigate its environmental impact. In summary, Worldwide Clinical Trials is dedicated to climate commitments, with a clear focus on achieving net-zero emissions, although specific emissions data has not been disclosed.
How Carbon Intensive is Worldwide's Industry?
How Carbon Intensive is Worldwide's Location?
Worldwide's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Worldwide has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.